The Rybelsus prescribing information for the tablet formulation of semaglutide co-formulated with the absorption enhancer SNAC, where absorption predominantly occurs in the stomach and might plausibly be more sensitive to acid suppression also reports no clinically significant differences in semaglutide pharmacokinetics with concomitant omeprazole
Its hard to tell, as each person has their own level of damage
My name is Courtney Reed and I live in Kelowna, BC
Toxicology and industrial health, 28(8), 758768.
But I think that this bill should include some more admin, lightening the load for admin as far as prohibiting non medical switching or formula exclusions
Store in a cool, dry place, away from direct heat and light